Skip to main content
. 2015 Nov 11;142:1659–1671. doi: 10.1007/s00432-015-2064-5

Fig. 3.

Fig. 3

Vorinostat inhibits HDAC activity by binding to the pocket of the catalytic site. The hydroxamic acid moiety of vorinostat binds to a zinc atom (pink); this allows the rest of the molecule to lie along the surface of the HDLP protein. Adapted from Marks et al. (2001)